People above 18 to be eligible for vaccine from May 1 in India

New Delhi: People above the age of 18 years will be made eligible for COVID vaccination from May 1 as the Centre reportedly announced this after a meeting with Prime Minister Narendra Modi on Monday.

Amid the rising COVID cases in the country, PM Modi held series of meetings with top officials to churn out measures to tackle the new virus threat. Implying the importance of vaccination, terming it the biggest weapon, PM urged doctors to encourage people to get vaccinated.

The government announced that the vaccination drive will be held as earlier. Coronavirus vaccines will be free of cost at all government-run COVID centres, while private hospitals can "transparently declare" a self-set cost for the vaccine.

Covid-19 Vaccination Phase 3: How to Register

1. Visit the official website of CoWIN cowin.gov.in

2. Enter your 10-digit mobile number or Aadhaar number

3. Enter the OTP received on the mobile number in the given space

4. Once registered, schedule your preferred date and time.

5. Get your COVID-19 vaccination done.


After this, you will get a Reference ID via which you can get your vaccination certificate.

Covid-19 Vaccination Phase 3: Documents Required

You will need at least one of the following documents at the time of registration, along with a Photo ID

Aadhaar Card

PAN Card

Voter ID

Driving License

Health Insurance Smart Card issued under by Ministry of Labour

Mahatma Gandhi National Rural Employment

Guarantee Act (MGNREGA) Job Card

Official identity cards issued to MPs/MLAs/MLCs

Passport

Passbooks issued by Bank/Post Office

Pension Document

Service Identity Card issued to employees by Central/ State Govt./ Public Limited Companies

The government said procurement, eligibility, administration of coronavirus vaccines are being made flexible. As per the order, vaccine manufacturers would supply 50 per cent of their monthly Central Drugs Laboratory released doses to the Government of India and would be free to supply the remaining 50 per cent doses to state governments and in the open market.